Showcasing new technologies, building new energy, and developing new industries.
Advantages
Home » About Us » Advantages

Introduction To Gansu Junmao New Material Technology Co., Ltd

Gansu Junmao New Material Technology Co., Ltd. was established on January 4, 2019. It is a high-tech enterprise specializing in the research and development and production of hydrides and reducing agents. Our company, based on advanced production technology and innovative development concepts, has created a full industry chain advantage with hydride and reducing agents as the core, integrating research and development, production, sales, operation, and a series of product production and services. The company mainly operates products such as lithium aluminum hydride, lithium borohydride, tert butoxy aluminum hydride, tert butoxy boron hydride, lithium aluminum deuteride, lithium deuteride, lithium hydride, calcium hydride, low nitrogen calcium hydride, aluminum trichloride, lithium chloride, etc. It not only provides high-quality and affordable products, but also provides safe and reliable services.
During the cooperation period, our company operates with integrity, relying on market information, understanding customer needs, respecting customer opinions, actively meeting customer customization needs for products, improving customer satisfaction with the company and products, solving problems with a good attitude, and creating a consumption environment that satisfies customers.
At the same time, our company has integrated services for research, development, production, and sales. Our products have undergone multiple research and experiments by the company's R&D team, and during production, production workers strictly control product quality. Our company's quality inspection department will adopt a sampling survey method to conduct testing and testing of products, resolutely preventing inferior products from entering the market, and ensuring the quality control of products.
Our company and partners are established on the basis of long-term trust, mutual benefit, and mutual support for each other's business development. We respect and maintain each other's corporate culture and business philosophy, and establish a sustainable development relationship of win-win cooperation.
Our company has many partners, and the following is an introduction to some of them
  • Kailaiying Pharmaceutical Group is a leading global CDMO company that provides high-quality one-stop services for the research and production of new drugs worldwide. Taking accelerating the launch of new drugs and extending the quality of life as our own responsibility, relying on continuous technological innovation, we provide one-stop CMC services throughout the entire drug lifecycle for domestic and foreign pharmaceutical and biotechnology companies, accelerating the development and application of new drugs.

    Currently, it has 8 major R&D and production bases worldwide, over 20 companies, and over 9800 employees. The business scope covers the early clinical stage to the commercialization stage, including the research and development of advanced intermediates, raw materials, formulations, and cGMP production, as well as clinical research services. And through strategic cooperation and business expansion, we will gradually build an integrated service ecosystem for innovative drugs and become partners in global new drug research and production.
  • Shanghai Yaoming Kangde New Drug Development Co., Ltd. was established on April 2, 2002, providing integrated, end-to-end new drug research and production services for the global biopharmaceutical industry. It has operating bases in Asia, Europe, North America, and other places. The service scope of WuXi KangDe covers the fields of chemical drug research and production, biological research, preclinical testing and clinical trial research and development, cell and gene therapy research and development, testing and production, and is committed to bringing more new and good drugs to patients worldwide, and realizing the vision of "making the world without difficult drugs and difficult diseases" as soon as possible.
  • Hequan Pharmaceutical serves the life science industry and has excellent capabilities and technological platforms for the research and production of innovative chemical drugs. As a leading enterprise in the field of global new drug contract research, development, and production, Hequan Pharmaceutical is committed to providing efficient, flexible, and high-quality one-stop solutions to global partners to support the research and production of small molecules, oligonucleotides, peptides, and various complex chemically coupled drugs. Hequan Pharmaceutical is committed to an integrated platform for drug development and production from preclinical to commercial, providing high-quality and efficient personalized solutions for global partners engaged in new drug development.
Gansu Junmao New Material Technology Co., Ltd. was established on January 4, 2019. It is a high-tech enterprise specializing in the research and development and production of hydrides and reducing agents.
Leave a Message
Get A Quote

Links

Category

Contact Us

  +86-022-23757385
   +86-18522605194
  jiyy@jm-hydride.com
  Room 301, No. 1346 Daxiahe Street, Qinchuan Fine Chemical Park, Lanzhou New Area, Lanzhou City, Gansu Province, China
​Copyright © 2023 Gansu Junmao New Materials Technology Co., Ltd. All rights reserved. | Sitemap | Privacy Policy | Supported by leadong.com